Journal
NATURE CELL BIOLOGY
Volume 15, Issue 8, Pages 895-U300Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb2790
Keywords
-
Categories
Funding
- NIH [N5069375, HL061535, P50CA058236, HL096113, HL100397, AG020961, AG009521]
- American Heart Association Scientist Development Grant [10SDG3510024]
- NIH/NIAMS [AR057220, R01CA84628]
- NIHSPORE in ProstateCancer
- Robert A. and Renee E. Belfer Foundation
- MDA [4320]
- Baxter Foundation
Ask authors/readers for more resources
Duchenne muscular dystrophy (DMD), the most common inherited muscular dystrophy of childhood, leads to death due to cardiorespiratory failure. Paradoxically, mdx mice with the same genetic deficiency of dystrophin exhibit minimal cardiac dysfunction, impeding the development of therapies. We postulated that the difference between mdx and DMD might result from differences in telomere lengths in mice and humans. We show here that, like DMD patients, mice that lack dystrophin and have shortened telomeres (mdx/mTR(KO)) develop severe functional cardiac deficits including ventricular dilation, contractile and conductance dysfunction, and accelerated mortality. These cardiac defects are accompanied by telomere erosion, mitochondrial fragmentation and increased oxidative stress. Treatment with antioxidants significantly retards the onset of cardiac dysfunction and death of mdx/mTR(KO) mice. In corroboration, all four of the DMD patients analysed had 45% shorter telomeres in their cardiomyocytes relative to age- and sex-matched controls. We propose that the demands of contraction in the absence of dystrophin coupled with increased oxidative stress conspire to accelerate telomere erosion culminating in cardiac failure and death. These findings provide strong support for a link between telomere length and dystrophin deficiency in the etiology of dilated cardiomyopathy in DMD and suggest preventive interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available